IHC-plus(tm) ABL1 / c-ABL Antibody

LifeSpan BioSciences

IHC-plus(tm) ABL1 / c-ABL Antibody

23

The predicted MW is 122kDa/124kDa, while the observed MW by Western blot was 139kDa.

ImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

IF, IHC (1:100 - 1:200), IHC-P (1:100 - 1:200), WB (1:500 - 1:2000) The predicted MW is 122kDa/124kDa, while the observed MW by Western blot was 139kDa.

Research Use Only

Polyclonal

0.22 mg/ml

Unconjugated

ABL1

ABL proto-oncogene 1, non-receptor tyrosine kinase

ABL, BCR-ABL, CHDSKM, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl, tyrosine-protein kinase ABL1, ABL protooncogene 1 nonreceptor tyrosine kinase, Abelson tyrosine-protein kinase 1, BCR-ABL1 p190, BCR/ABL e8a2 fusion, BCR/ABL1 e1a2 fusion protein, BCR/ABL1 fusion, BCR/ABL1 fusion protein e3a1, BCR::ABL1 fusion protein, bcr/c-abl oncogene protein, c-abl oncogene 1, receptor tyrosine kinase, chimeric BCR::ABL1 protein, proto-oncogene c-Abl, proto-oncogene tyrosine-protein kinase ABL1, v-abl Abelson murine leukemia viral oncogene homolog 1

Rabbit

IgG

Human, Mouse, Rat

-20°C

41116161